Drug Type Small molecule drug |
Synonyms Etrabamine, 14 839JL, 14-839JL + [3] |
Target |
Action agonists |
Mechanism D2 receptor agonists(Dopamine D2 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC8H13ClN2S |
InChIKeyQUEDYVUOFCKNCQ-UHFFFAOYSA-N |
CAS Registry70590-44-2 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Parkinson Disease | Phase 2 | - | - |





